Blood platelets and resident neurons are fundamentally different cells, with peculiar features in embryological origin, function, and localization. However, they share common characteristics in subcellular organization and in protein composition. 1 One of the most intriguing observations is that several proteins are typically expressed in both neurons and circulating platelets. In the latter, their concentrations are unusually high, and they are found to regulate processes such as platelet activation, hemostasis, and thrombosis. Four excellent examples are: 1. The neuronal protein reelin, which regulates cell migration and synaptic plasticity, is present in plasma and in blood platelets where it regulates arterial thrombosis. 2,3 2. Amyloid Aβ peptides, which accumulate in senile plaques in Alzheimer disease, and the amyloid precursor protein (APP) are expressed in megakaryocytes, are stored in platelet α-granules, and are released upon platelet activation. APP controls coagulation and thrombosis, 4,5 whereas amyloid Aβ peptides stimulate platelet aggregation. 6
1. The neuronal protein reelin, which regulates cell migration and synaptic plasticity, is present in plasma and in blood platelets where it regulates arterial thrombosis. 2, 3 2. Amyloid Aβ peptides, which accumulate in senile plaques in Alzheimer disease, and the amyloid precursor protein (APP) are expressed in megakaryocytes, are stored in platelet α-granules, and are released upon platelet activation. APP controls coagulation and thrombosis, 4, 5 whereas amyloid Aβ peptides stimulate platelet aggregation. 6 3. Brain-derived neurotrophic factor, which is implicated in the pathophysiology of depression, is synthesized in megakaryocytes and accumulates in platelets, where it modulates thrombosis. 7, 8 4. The neurotransmitter serotonin, which has important roles in controlling behavior and sociality, is stored in platelet-dense granules where it is released upon activation to act as a weak agonist. 9 Because of these and other parallelisms, circulating platelets have correlate with ASD. The expression, but not the affinity of the serotonin transporter SERT, is increased on the surface of ASD platelets, and integrin αIIbβ3 directly interacts with SERT. Also, metabolism of the serotonin derivatives N-acetyl serotonin and melatonin is altered in ASD platelets. Finally, platelet alterations in dense granule contents and in platelet function have been observed in ASD patients. 10 
